FDA Inspection
Recipharm Pharmaservices Private LimitedRecipharm Pharmaservices Private Limited – FDA Inspection, May 11, 2018
Record Details
This FDA Inspection record concerns Recipharm Pharmaservices Private Limited, with an inspection on May 11, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a2baf591-c4b2-4164-9b3b-be80c923d53e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1053644
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Recipharm Pharmaservices Private Limited
8| Date | Classification | Office | Project area |
|---|---|---|---|
| March 22, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 13, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 7, 2018 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| December 14, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Recipharm Pharmaservices Private Limited
- FDA Inspection 1232473 - 2024-03-22
- FDA Inspection 1119410 - 2020-02-13
- FDA Inspection 1079034 - 2019-02-01
- FDA Inspection 1075220 - 2018-12-07
- FDA Inspection 1037690 - 2017-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.